Biochemical basis of neuropsychiatric disorders Flashcards
what are the biogenic amines
acetyl choline dopamine norepinephrine epinephreine serotonin malatonin histamine
what are the biogenic amines derived from tyrosine
DA, NE, and epi
what are the biogenic amines derived from indolamines
5Ht and melatonin,
what are the amino acid neurotransmitters
glu, asp, gly, GABA, ser, Cys
names of the purigenic neurotransmitters
adenosine, UTP, ATP, ADP and ApnA (diadenosine)
D1 and D2
excitatory, increase cAMP
D2-D4
inhibitory, decreases cAMP
5HT1 and 5Ht5
inhibitory, decreases cAMP
5Ht2
excitatory, increases IP3/DAG
5Ht3
excitatory, ligand gated sodium channel
5HT4,6,7
excitatory increases cAMP
alpha 1
excitatory, increases IP3, DAG, NE>EPi
alpha 2
inhibitory- decreases CAMP, epi> NE
beta 123
excitatory, increases cAMP
H1
excitatory, increases IP3 and DAG
H2
excitatory increases cAMP
H3,4
inhibitory- decreases cAMP
N12
excitatory, ligand gated sodium channel
M13,5
excitatory, increases IP3, DAG
M2,4
decreases cAMP
AMPA and kainate
excitatory sodium channels
NMDA
excitatory sodium and calcium channels
mGLU R 1 and 5
excitotry increases IP3, DAG (class I)
mGLU r 2,3,4,6,7,8
inhibitory, decreases cAMP
GABA receptors
all are inhibitory
GABAa
ligand gated chloride channel
GABAb
second messenger triggered potassium channel
GABAc
ligand gated chloride channel
Gly
inhibitory, ligand gated chlroide channel
all neurohomrone s
exchitatory, increased IP3 and DAG except arginine vasopresin receptor 2
all tachykinin receptors
excitatory increases IP3 and DAG
delta, leu-met-enkephalin
2nd messenger trigger potassium channel
kappa, dynorphin
inhibitory decreases caMP
mu, enkelphins and endorphins
2nd messenger, triggered potassium channel
what are the clinical characteristics of parkinson’s disease
tremos, kradykinesia, rigidity, and postural instability
lewy bodies are characteristic of what disease ?
parkinson’s disease
loss of what is characteristic of parkinson’s disease
substantia nigra
what commonly coexists with parkinson’s disease
alzheimer disease
where is dopamine found
midbrain, substansia nigra, pars compacta and ventral tegmental area
main targets of dopamine
striatum, limbic cortex, amygdala, nucleus acumbens, prefrontal cortex (D1-5), movements, initiative, working memory
what is the function of dopamine
movements, initative and working memory
substantia nigra pars compact pathway
mesostraital (migrostraital) to straitum (putamen and caudate
what is the mesolimbic pathway
VTA to limbic (cingulate corttex)